F 0645
PASARR screening for Mental disorders or Intellectual Disabilities
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observations, interviews, record reviews, and facility policy and procedure review, the facility failed to
provide two (Residents #82 and #62) of four residents with diagnoses of a serious mental illness (SMI) with
Level II preadmission screening and resident review (PASRR) screenings as required, from a total survey
sample of 34 residents.
Residents Affected - Few
The findings include:
1. A review of Resident #82's medical record revealed she was admitted to the facility on [DATE], with
diagnoses including, but not limited to, unspecified dementia, bipolar disorder, insomnia, other specified
depressive episodes, and Pseudobulbar affect.
A review of her annual minimum data set (MDS) assessment, dated 6/10/24, revealed that in Section
A1500, the resident had not been evaluated by Level II PASRR and had no serious mental illness (SMI) or
intellectual disability (ID). Section I of the assessment indicated a diagnosis of non-Alzheimer's dementia,
anxiety disorder, depression, bipolar disease, and Pseudobulbar affect. The resident received antipsychotic,
antianxiety, and antidepressant medications during the look-back period.
A review of the resident's physician's orders revealed the following:
Resident received Abilify 5 mg (milligrams), take 0.5 tablet at bedtime for diagnosis: Bipolar Disorder
(4/2/24)
Ativan (antianxiety medication) 0.5 mg by mouth, Indication: yelling out (4/16/24)
Nudexta 20 - 10 mg by mouth twice daily, Indication: Pseudobulbar affect (11/13/23)
Remeron 15 mg by mouth, give 7.5 mg daily for decreased appetite (6/27/24)
Further review of the resident's record revealed a Level 1 PASRR dated 6/9/20, completed by the acute
care hospital prior to the resident's nursing home admission. This PASRR triggered a Level II PASRR for
serious mental illness. A Level II PASRR was unavailable in the resident's electronic medical record (EMR).
On 8/13/24 at 12:36 PM, an interview was conducted with the Regional Nurse Consultant (RNC) who was
providing documents unavailable in the EMR to the surveyor. She was asked to review Resident #82's Level
1 PASRR results to verify that the Level 1 PASRR triggered a Level II PASRR. She was asked to provide
the Level II PASRR that was indicated by the Level 1 PASRR dated 6/9/20. She provided the
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
105423
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105423
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/15/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Terrace of Jacksonville, The
10680 Old St Augustine Rd
Jacksonville, FL 32257
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0645
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Resident Review (RR) evaluation request, completed by the acute care hospital on 6/9/20. She said she did
not know why a Level II PASRR was not completed at that time; it was prior to her employment with the
company.
A review of the facility's policy titled PASARR, 2001 MED-PASS, Inc. (Revised March 2019, reviewed
08/2021, 06/2023, 01/2024) revealed:
1b. If the Level 1 screen indicates that the individual may meet the criteria for a MD, ID, or RD, he or she is
referred to the state PASSAR representative for the Level II (evaluation and determination) screening
process.
2. A review of Resident #62's medical record on 8/13/24 at 11:04 AM, revealed diagnoses of dementia and
major depressive disorder dated 10/13/21, that were not identified on the resident's PASRR dated 2/3/18.
A review of Resident #62's medicalrecord revealed an readmission date of 12/16/22 and an initial
admission date of 2/16/18. Her diagnoses included unspecified dementia, psychotic disturbance, mood
disturbance, anxiety, major depressive disorder, other specified anxiety disorders, paranoid schizophrenia,
and insomnia. Resident #62's active physician's orders included Buspirone 10 mg (milligrams) for anxiety
two times daily at 6:00 AM and 6:00 PM, started on 5/23/23; Citalopram 10 mg via gastric tube once a day
at 6:00 AM for depression, starting on 5/11/23; and Seroquel (quetiapine - antipsychotic) 25 mg via gastric
tube at bedtime at 9:00 PM for depression, started on 6/13/24.
A review of the MDS assessment, dated 7/12/24, revealed that the resident was readmitted from an acute
care hospital. Section A1550 related to PASRR was blank. The resident's brief interview for mental status
(BIMS) was completed by staff and indicated that the resident's cognitive skills for daily decision-making
were moderately impaired - decisions poor, cues/supervision required.
An interview was conducted with the Social Services Director (SSD) on 8/15/24 at 12:09 PM. She stated
nursing assisted her with completing the resident assessments to identify a history of depression.
Assessments were completed as needed and quarterly. If signs of depression were identified, the resident
would be referred to the psychiatric team. A resident identified as having a newly evident or possible mental
disorders (MD), ID, or related condition after admission, would be assessed to ensure they had a disorder.
Residents found to have a disorder were reported and referred to determine whether a PASRR Level II was
needed. The SSD stated she was responsible for ensuring that a referral was sent to the appropriate
state-designated authority.
An interview was conducted with the Director of Nursing (DON) on 8/15/24 at 12:25 PM. She stated the
facility's process for identifying residents with a possible MD, ID, or related condition prior to admission, was
to consult with the Interdisciplinary Team and refer to psychiatric services for evaluation. Residents with
newly evident or possible serious mental conditions, after admission to the facility, hospital documentation
as well as observations for signs or symptoms related to behaviors were reviewed and evaluated. If issues
or concerns were identified, the physician was contacted and a psychiatric consult and review of
medications was completed. The SSD completed the PASRR and worked with the Administrator to refer the
resident to the appropriate state-designated authority. The process was to collaborate with the
Interdisciplinary Team, stabilize the resident, and/or [NAME] Act the resident, if necessary, to ensure other
residents were kept safe. When she was asked if a PASRR Level II was required for Resident #62, the DON
confirmed that Resident #62 required a PASRR Level II screening.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105423
If continuation sheet
Page 2 of 3
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105423
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/15/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Terrace of Jacksonville, The
10680 Old St Augustine Rd
Jacksonville, FL 32257
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0645
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
A review of the facility's policy and procedure titled PASARR (revised date 03/2019), revealed: Policy
Statement: Our facility admits only residents whose medical and nursing care needs can be met. Policy
Interpretation and Implementation: 1. All new admissions and readmissions are screened for mental
disorders (MD), intellectual disabilities (ID) or related disorders (RD) per the Medicaid Pre-admission
Screening and Resident Review (PASARR) process. a. the facility conducts a level l PASARR screen for all
potential admissions, regardless of payer source, to determine if the individual meets the criteria for a MD,
ID or RD. b. if the level l screen indicates that the individual may meet the criteria for a MD, ID, or RD, he or
she is referred to the state PASARR representative for the Level ll (evaluation and determination) screening
process. 1. The admitting nurse notifies the social services department when a resident is identified as
having a possible (or evident) MD, ID, or RD. 2. The social worker is responsible for making referrals to the
appropriate state-designated authority. c. Upon completion of the Level II evaluation, the State PASARR
representative determines if the individual has a physical or mental condition, what specialized or
rehabilitative services he or she needs. And whether placement in the facility is appropriate. d. The State
PASARR representative provides a copy of the report to the facility. e. The interdisciplinary team determines
whether the facility is capable of meeting the needs and services of the potential resident that are outlined
in the evaluation. f. Once a decision is made, the State PASARR representative, the potential resident and
his or her representative are notified.
.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105423
If continuation sheet
Page 3 of 3